이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System ((JJ-TRAILS))

2019년 7월 22일 업데이트: Michael L. Dennis, Ph.D., Chestnut Health Systems

Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System: Multi-site Implementation Study

This is a multi site experiment to evaluate the impact of various strategies for increasing the use of evidence based screening, assessment and linkage to substance use treatment. All sites collect baseline data and receive a core intervention. Half are then randomly assigned to get an additional year of coaching to facilitate implementation.

연구 개요

상태

완전한

상세 설명

Background: The Juvenile Justice-Translational Research on Interventions for Adolescents in the Legal System (JJ-TRIALS) study is a cooperative implementation science initiative involving the National Institute on Drug Abuse, six Research Centers, a Coordinating Center, and Juvenile Justice Partners representing seven U.S. states. The pooling of resources across Centers enables a robust implementation study design involving 36 juvenile justice agencies and their behavioral health partner agencies, coproducing a study protocol that has potential to advance implementation science, meets the needs of all constituencies (funding agency, researchers, partners, study sites), and can be implemented with fidelity across the cooperative can be challenging.

Methods/design: The JJ-TRIALS primary study uses a head-to-head cluster randomized trial with a phased rollout to evaluate the differential effectiveness of two conditions (Core and Enhanced) in 36 sites located in 7 states. Core strategies for promoting change are compared to an Enhanced strategy that incorporate all core strategies plus active facilitation. Target outcomes include improvements in evidence-based screening, assessment, and linkage to substance use treatment.

Primary Research Questions:

  1. Does the Core and/or Enhanced Intervention reduce unmet need by increasing Cascade retention related to screening, assessment, treatment initiation, engagement and continuing care?
  2. Does the addition of the Enhanced Intervention components further increase the percentage of youth retained in the Cascade relative to the Core components?
  3. Does the addition of the Enhanced Intervention components improve service quality relative to Core sites?
  4. Do staff perceptions of the value of best practices increase over time, and are increases more pronounced in Enhanced sites?

연구 유형

중재적

등록 (실제)

839

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Georgia
      • Atlanta, Georgia, 미국, 30322
        • Emory University
    • Illinois
      • Bloomington, Illinois, 미국, 61701
        • Chestnut Health Systems
    • Kentucky
      • Lexington, Kentucky, 미국, 40508
        • University of Kentucky
    • Maryland
      • Rockville, Maryland, 미국, 20892
        • National Institute on Drug Abuse
    • Mississippi
      • Starkville, Mississippi, 미국, 39759
        • Mississippi State University
    • New York
      • New York, New York, 미국, 10032
        • Columbia University
    • Pennsylvania
      • Philadelphia, Pennsylvania, 미국, 19122
        • Temple University
    • Texas
      • Fort Worth, Texas, 미국, 76129
        • Texas Christian University

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 어린이
  • 성인
  • 고령자

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Specific site inclusion criteria include: (a) ability to provide youth service records, (b) service to youth under community supervision, (c) access to treatment provider(s) if treatment is not provided directly by the JJ agency, (d) participation in requisite intervention training/activities,(e) minimum average case flow of 10 youth per month, (f) minimum of 10 staff per site, and (g) a senior JJ staff member who agrees to serve as site leader/liaison during the study. Study sites are geographically dispersed and were identified by state JJ agencies (and not selected for particular substance use or related BH service needs).

Youth inclusion criteria include: all youth entering the juvenile justice system during the period within the exception of those who are already in treatment at the time that they are referred to the juvenile justice agency.

Staff inclusion criteria include: all staff actively working with the youth under community supervision in the site with exclusion only of higher level administrative or regional staff over multiple units..

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 건강 서비스 연구
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 삼루타

무기와 개입

참가자 그룹 / 팔
개입 / 치료
간섭 없음: Control
During the Baseline Control data is collected in all 36 sites at the agency, staff, and youth level on the 6 months prior to the interventions in Arms 2 & 3 to document what practice was before the study.
활성 비교기: Core

In the second phase (after baseline) all 36 sites receive a Core condition that includes five interventions: (1) JJ-TRIALS Orientation Meetings, (2) Needs Assessment, (3) Behavioral Health Training, (4) Site Feedback Report, (5) Goal Achievement Training, (6) Monthly Site Check-ins, and (7) Quarterly Reports. As part of Goal Achievement Training, sites receive assistance in using their Site Feedback Reports to select goals to meet their local needs. Sites are trained on using Data-Driven Decision Making (DDDM) to inform decisions (e.g., selecting a goal, monitoring progress) and enlisting DDDM templates and tools (developed as part of the project) to plan and implement proposed changes.

these principles to their improvement efforts during the implementation phase.

다른 이름들:
  • GAT, DDDM
실험적: Enhanced
While the core intervention and DDDM are expected to facilitate change, organizations may need additional support to apply these principles to their improvement efforts during the implementation phase. In the third phase (after Core), 1/2 of the sites are randomly assigned to an Enhanced condition that provides continuing support for the use of DDDM tools by adding research staff facilitation of DDDM over a 12-month period and formalized Local Change Teams (LCTs) featuring representation from the JJ agency and a local BH provider, with meetings facilitated by research staff).
다른 이름들:
  • GAT, DDDM
다른 이름들:
  • DDDM, Facilitation

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Service Cascade: % Referred to Substance Use Treatment
기간: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the number of youth referred to substance use treatment divided by the number of youth identified as need of substance use treatment.
120 weeks
Staff Perception: Value of Evidenced Based Substance Use Treatment
기간: 120 weeks
Calculated from staff surveys at juvenile justice and substance use treatment agencies as the average staff ranking of the perceived "value" of using of evidence-based substance use treatment services.
120 weeks

2차 결과 측정

결과 측정
측정값 설명
기간
Service Cascade: % Screened for Substance Use Problems
기간: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the number of youth "Screened" for substance use problems divided by the number of youth entering the juvenile justice system.
120 weeks
Service Cascade: % Clinically Assessed for Substance Use Problems
기간: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the number of youth "Clinically Assessed" for substance use problems divided by the number of youth entering the juvenile justice system.
120 weeks
Service Cascade: % In Need of Substance Use Treatment
기간: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the number of youth identified (via screening, clinical assessment or other sources) as "In Need of Substance Use Treatment" divided by the number of youth entering the juvenile justice system.
120 weeks
Service Cascade: % Initiating Substance Use Treatment
기간: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the number of youth "Initiating" Substance Use Treatment within 90 days of referral" divided by the number referred to treatment from the juvenile justice system.
120 weeks
Service Cascade: % Engaged in Substance Use Treatment
기간: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the number of youth "Engaged" in Substance Use Treatment for 6 weeks or more weeks divided by the number initiating treatment.
120 weeks
Service Cascade: % With Substance Use Treatment Continuing Care
기간: 120 weeks
number of youth "Continuing" to receive substance use treatment services forCalculated from juvenile justice and substance use treatment agency records as the 90 days or more divided by the number initiating treatment.
120 weeks
Service Quality: Timing of Screening or Clinical Assessment
기간: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the mean days from entry into the justice system to the first of screening or clinical assessment for substance use problems.
120 weeks
Service Quality: Timing of Substance Use Treatment Initiation
기간: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the mean days from referral to and initiation of substance use treatment.
120 weeks
Service Quality: Number of Evidence Based Practices
기간: 120 Weeks
Based on agency surveys and youth records from juvenile justice and substance use treatment agencies, the number of steps using 1 or more evidenced based practices in each of the following steps along the service cascade: screening, clinical assessment, referral, substance use treatment.
120 Weeks
Staff Perception: Value of Evidenced Based Screening
기간: 120 weeks
Calculated from staff surveys at juvenile justice and substance use treatment agencies as the average staff ranking of the perceived "value" of using of evidence-based screening.
120 weeks
Staff Perception: Value of Evidenced Based Clinical Assessment
기간: 120 weeks
Calculated from staff surveys at juvenile justice and substance use treatment agencies as the average staff ranking of the perceived "value" of using of evidence-based clinical assessment.
120 weeks
Staff Perception: Value of Evidenced Based Substance Use Prevention
기간: 120 weeks
Calculated from staff surveys at juvenile justice and substance use treatment agencies as the average staff ranking of the perceived "value" of using of evidence-based substance use prevention.
120 weeks
Staff Perception: Value of Evidenced Based HIV Risk Prevention
기간: 120 weeks
Calculated from staff surveys at juvenile justice and substance use treatment agencies as the average staff ranking of the perceived "value" of using of evidence-based HIV Risk prevention.
120 weeks

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Christy K Scott, Ph.D., Chestnut Health Systems
  • 수석 연구원: Danica K Knight, Ph.D., Texas Christian University
  • 수석 연구원: Michael L Dennis, Ph.D., Chestnut Health Systems
  • 수석 연구원: Tisha R Wiley, Ph.D., National Institute on Drug Abuse (NIDA)
  • 수석 연구원: Gail A Wasserman, Ph.D., Columbia University
  • 수석 연구원: Ralph DiClemente, Ph.D., Emory University
  • 수석 연구원: Gene H Brody, Ph.D., Emory University
  • 수석 연구원: Angela A Robertson, Ph.D., Mississippi State University
  • 수석 연구원: Steven R Belenko, Ph.D., Temple University
  • 수석 연구원: Carl G Leukefeld, Ph.D., University of Kentucky

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

일반 간행물

유용한 링크

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2013년 7월 1일

기본 완료 (실제)

2019년 1월 31일

연구 완료 (실제)

2019년 6월 30일

연구 등록 날짜

최초 제출

2016년 1월 22일

QC 기준을 충족하는 최초 제출

2016년 1월 29일

처음 게시됨 (추정)

2016년 2월 3일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2019년 7월 23일

QC 기준을 충족하는 마지막 업데이트 제출

2019년 7월 22일

마지막으로 확인됨

2019년 7월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • JJ-TRIALS
  • U01DA036221 (미국 NIH 보조금/계약)
  • U01DA036226 (미국 NIH 보조금/계약)
  • U01DA036233 (미국 NIH 보조금/계약)
  • U01DA036176 (미국 NIH 보조금/계약)
  • U01DA036225 (미국 NIH 보조금/계약)
  • U01DA036224 (미국 NIH 보조금/계약)
  • U01DA036158 (미국 NIH 보조금/계약)

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

예

IPD 계획 설명

The coordinating center is charged with creating de-identified versions of agency, staff and client level service data available at the end of the study.

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다